Charlottesville, Oct 10, 2009/ Biovista announced today that its President Dr. Aris Persidis will present at the Life Sciences and Healthcare Venture Summit being held on October 27th, at NYC.

Dr. Persidis will discuss Biovista’s repositioning program including BVA-201 for MS and BVA-601 for epilepsy. He will also provide an overview of Biovista’s business model and plans taking the company forward.

The Life Sciences and Healthcare Venture Summit is a premier bioscience industry gathering, connecting senior executives of early stage biotech, pharmaceutical, healthcare, medical device and diagnostic companies with venture capitalists, angel investors, corporate VCs and professional service firms.